BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $145 | -54.5% | 113 | 0.0% | 0.00% | – |
| Q1 2024 | $319 | -4.2% | 113 | 0.0% | 0.00% | – |
| Q4 2023 | $333 | +16.4% | 113 | 0.0% | 0.00% | – |
| Q3 2023 | $286 | -62.0% | 113 | 0.0% | 0.00% | – |
| Q2 2023 | $753 | -64.3% | 113 | 0.0% | 0.00% | – |
| Q1 2023 | $2,109 | -13.1% | 113 | 0.0% | 0.00% | – |
| Q4 2022 | $2,427 | +81.7% | 113 | 0.0% | 0.00% | – |
| Q3 2022 | $1,336 | -10.5% | 113 | 0.0% | 0.00% | – |
| Q2 2022 | $1,492 | -36.9% | 113 | 0.0% | 0.00% | – |
| Q1 2022 | $2,363 | – | 113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $7,040,000 | 3.41% |
| Ikarian Capital, LLC | 693,716 | $15,505,000 | 1.17% |
| EAM Global Investors LLC | 71,838 | $1,606,000 | 0.94% |
| Avidity Partners Management LP | 211,000 | $4,716,000 | 0.65% |
| MOODY ALDRICH PARTNERS LLC | 79,642 | $1,780,000 | 0.54% |
| Knoll Capital Management, LLC | 20,000 | $447,000 | 0.42% |
| EAM Investors, LLC | 55,775 | $1,247,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 299,932 | $6,703,000 | 0.22% |
| Coastal Bridge Advisors, LLC | 25,014 | $559,000 | 0.20% |
| Ikarian Capital, LLC | 103,300 | $2,309,000 | 0.17% |